Anticoagulant-free Genius® haemodialysis using low molecular weight heparin-coated circuits

被引:27
作者
Frank, RD
Müller, U
Lanzmich, R
Groeger, C
Floege, J
机构
[1] Univ Hosp Aachen, Dept Nephrol & Clin Immunol, Aachen, Germany
[2] BMP Lab Med Mat Testing, Aachen, Germany
[3] Artificial Organ Technol, Bad Oeynhausen, Germany
关键词
haemodialysis; low molecular weight heparin; surface coating;
D O I
10.1093/ndt/gfi293
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Regional citrate anticoagulation or saline flushes are often used in haemodialysis patients at high risk of bleeding. In an alternative approach we evaluated the effects of covalent circuit coating with low molecular weight heparin (LMWH) for intermittent haemodialysis. Methods. In vitro, we compared the thrombogenicity of an uncoated polyvinylchloride (PVC) tubing set with LMWH-coated tubing (AOThel (R)) and a reference tubing with end-point attached heparin coating (Carmeda (R) Bioactive surface) under dynamic blood contact. In vivo, five chronic haemodialysis patients were studied using the Genius (R) dialysis system and F60S (R) filters. Each patient underwent three dialysis sessions separated by a standard haemodialysis each: (1) standard dialysis (uncoated circuit and regular dalteparin dosage), (2) dialysis with LMWH-coated circuit and regular dalteparin dosage and (3) dialysis with a completely LMWH-coated circuit without anticoagulant use. Results. In vitro, both coated tubings showed significantly reduced thrombin-antithrombin (TAT) complex levels compared with PVC. The reference coating (Carmeda (R)) released substantial antifactor Xa (antiXa) activity into the plasma. The LMWH coating (AOThel (R)) released low antiXa activity only during the initial rinsing. In vivo, all dialysis sessions were well tolerated and completed without major clotting. Antithrombin levels and platelet counts were similar in all groups. P-selectin and D-dimer levels increased similarly in all groups. TAT levels were comparable in all groups during the first 3 h and significantly increased in the anticoagulant-free group after the fourth hour. Conclusions. LMWH surface coating reduces thrombogenicity in vitro without releasing significant amounts of heparin from the surface. In vivo, anticoagulant-free haemodialysis using a completely LMWH-coated circuit is feasible and safe in stable chronic dialysis patients with normal coagulation.
引用
收藏
页码:1013 / 1018
页数:6
相关论文
共 30 条
  • [1] THROMBIN UPTAKE AND INHIBITION ON ENDOTHELIUM AND SURFACES WITH A STABLE HEPARIN COATING - A COMPARATIVE INVITRO STUDY
    ARNANDER, C
    DRYJSKI, M
    LARSSON, R
    OLSSON, P
    SWEDENBORG, J
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1986, 20 (02): : 235 - 246
  • [2] In vitro evaluation of new surface coatings for extracorporeal circulation
    Baksaas, ST
    Videm, V
    Fosse, E
    Karlsen, H
    Pedersen, T
    Mollnes, TE
    Hagve, TA
    Svennevig, JL
    [J]. PERFUSION-UK, 1999, 14 (01): : 11 - 19
  • [3] Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model
    Bannan, S
    Danby, A
    Cowan, D
    Ashraf, S
    Gesinde, M
    Martin, P
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (02) : 268 - 275
  • [4] Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit
    Barstad, RM
    Ovrum, E
    Ringdal, MA
    Oystese, R
    Hamers, MJAG
    Veiby, OP
    Rolfsen, T
    Stephens, RW
    Sakariassen, KS
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) : 517 - 525
  • [5] CHANDLER AB, 1958, LAB INVEST, V7, P110
  • [6] Dempfle CE, 2001, THROMB HAEMOSTASIS, V85, P671
  • [7] ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
  • [8] Renaissance of the batch method?
    Fassbinder, W
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) : 3010 - 3012
  • [9] REDUCING THE HEMORRHAGIC COMPLICATIONS OF HEMODIALYSIS - A CONTROLLED COMPARISON OF LOW-DOSE HEPARIN AND CITRATE ANTICOAGULATION
    FLANIGAN, MJ
    VONBRECHT, J
    FREEMAN, RM
    LIM, VS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 9 (02) : 147 - 153
  • [10] REDUCED COMPLEMENT AND GRANULOCYTE ACTIVATION WITH HEPARIN-COATED CARDIOPULMONARY BYPASS
    FOSSE, E
    MOEN, O
    JOHNSON, E
    SEMB, G
    BROCKMEIER, V
    MOLLNES, TE
    FAGERHOL, MK
    VENGE, P
    [J]. ANNALS OF THORACIC SURGERY, 1994, 58 (02) : 472 - 477